204 related articles for article (PubMed ID: 9388247)
21. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia.
Ikegawa S; Ohashi H; Nishimura G; Kim KC; Sannohe A; Kimizuka M; Fukushima Y; Nagai T; Nakamura Y
Hum Genet; 1998 Dec; 103(6):633-8. PubMed ID: 9921895
[TBL] [Abstract][Full Text] [Related]
22. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene.
Briggs MD; Hoffman SM; King LM; Olsen AS; Mohrenweiser H; Leroy JG; Mortier GR; Rimoin DL; Lachman RS; Gaines ES
Nat Genet; 1995 Jul; 10(3):330-6. PubMed ID: 7670472
[TBL] [Abstract][Full Text] [Related]
23. COMP and Col9A3 mutations and their relationship to the pseudoachondroplasia phenotype.
Jung WW; Balce GC; Cho JW; Jung SC; Hong SJ; Song HR
Int J Mol Med; 2010 Dec; 26(6):885-91. PubMed ID: 21042783
[TBL] [Abstract][Full Text] [Related]
24. A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis.
Hansen U; Platz N; Becker A; Bruckner P; Paulsson M; Zaucke F
Arthritis Rheum; 2011 Jan; 63(1):159-67. PubMed ID: 20936634
[TBL] [Abstract][Full Text] [Related]
25. Novel mutation in exon 18 of the cartilage oligomeric matrix protein gene causes a severe pseudoachondroplasia.
Mabuchi A; Haga N; Ikeda T; Manabe N; Ohashi H; Takatori Y; Nakamura K; Ikegawa S
Am J Med Genet; 2001 Nov; 104(2):135-9. PubMed ID: 11746044
[TBL] [Abstract][Full Text] [Related]
26. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.
Posey KL; Veerisetty AC; Liu P; Wang HR; Poindexter BJ; Bick R; Alcorn JL; Hecht JT
Am J Pathol; 2009 Oct; 175(4):1555-63. PubMed ID: 19762713
[TBL] [Abstract][Full Text] [Related]
27. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia -- multiple epiphyseal dysplasia disease group.
Kennedy J; Jackson GC; Barker FS; Nundlall S; Bella J; Wright MJ; Mortier GR; Neas K; Thompson E; Elles R; Briggs MD
Hum Mutat; 2005 Jun; 25(6):593-4. PubMed ID: 15880723
[TBL] [Abstract][Full Text] [Related]
28. Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum.
Briggs MD; Mortier GR; Cole WG; King LM; Golik SS; Bonaventure J; Nuytinck L; De Paepe A; Leroy JG; Biesecker L; Lipson M; Wilcox WR; Lachman RS; Rimoin DL; Knowlton RG; Cohn DH
Am J Hum Genet; 1998 Feb; 62(2):311-9. PubMed ID: 9463320
[TBL] [Abstract][Full Text] [Related]
29. Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutations in the calmodulin-like repeats of cartilage oligomeric matrix protein.
Susic S; McGrory J; Ahier J; Cole WG
Clin Genet; 1997 Apr; 51(4):219-24. PubMed ID: 9184241
[TBL] [Abstract][Full Text] [Related]
30. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
Chen TL; Posey KL; Hecht JT; Vertel BM
J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
[TBL] [Abstract][Full Text] [Related]
31. MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures.
Roman-Blas J; Dion AS; Seghatoleslami MR; Giunta K; Oca P; Jimenez SA; Williams CJ
J Cell Physiol; 2010 Sep; 224(3):817-26. PubMed ID: 20578249
[TBL] [Abstract][Full Text] [Related]
32. Secretion of cartilage oligomeric matrix protein is affected by the signal peptide.
Holden P; Keene DR; Lunstrum GP; Bächinger HP; Horton WA
J Biol Chem; 2005 Apr; 280(17):17172-9. PubMed ID: 15749701
[TBL] [Abstract][Full Text] [Related]
33. Health consequences of mutant cartilage oligomeric matrix protein and its relationship to abnormal growth and joint degeneration.
Hecht JT; Chiu F; Veerisetty A; Hossain M; Posey KL
Matrix Biol; 2023 May; 119():101-111. PubMed ID: 37001593
[TBL] [Abstract][Full Text] [Related]
34. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia.
Mabuchi A; Manabe N; Haga N; Kitoh H; Ikeda T; Kawaji H; Tamai K; Hamada J; Nakamura S; Brunetti-Pierri N; Kimizuka M; Takatori Y; Nakamura K; Nishimura G; Ohashi H; Ikegawa S
Hum Genet; 2003 Jan; 112(1):84-90. PubMed ID: 12483304
[TBL] [Abstract][Full Text] [Related]
35. Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family.
Holden P; Meadows RS; Chapman KL; Grant ME; Kadler KE; Briggs MD
J Biol Chem; 2001 Feb; 276(8):6046-55. PubMed ID: 11087755
[TBL] [Abstract][Full Text] [Related]
36. Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.
Alcorn JL; Merritt TM; Farach-Carson MC; Wang HH; Hecht JT
RNA; 2009 Apr; 15(4):686-95. PubMed ID: 19237461
[TBL] [Abstract][Full Text] [Related]
37. The murine COMP (cartilage oligomeric matrix protein) promoter contains a potent transcriptional repressor region.
Han F; Kipnes JR; Li Y; Tuan RS; Hall DJ
Osteoarthritis Cartilage; 2002 Aug; 10(8):638-45. PubMed ID: 12479386
[TBL] [Abstract][Full Text] [Related]
38. Identification of cartilage oligomeric matrix protein (COMP) gene mutations in patients with pseudoachondroplasia and multiple epiphyseal dysplasia.
Song HR; Lee KS; Li QW; Koo SK; Jung SC
J Hum Genet; 2003; 48(5):222-225. PubMed ID: 12768438
[TBL] [Abstract][Full Text] [Related]
39. Novel and recurrent exon 13 mutations of COMP in pseudoachondroplasia.
Nakashima E; Mabuchi A; Kubota M; Ishikiriyama S; Ohashi H; Nishimura G; Ikegawa S
Am J Med Genet A; 2005 Jan; 132A(1):108-9. PubMed ID: 15523619
[No Abstract] [Full Text] [Related]
40. Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias.
Mann HH; Ozbek S; Engel J; Paulsson M; Wagener R
J Biol Chem; 2004 Jun; 279(24):25294-8. PubMed ID: 15075323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
